Skip to main content
. 2019 May 16;8(10):e012161. doi: 10.1161/JAHA.119.012161

Table 1.

Baseline Characteristics According to MI Type and Sex

STEMI NSTEMI
Male (n=5114) Female (n=1317) P Value Male (n=5316) Female (n=1704) P Value
Age, y 60.8±12.2 66.5±13.2 <0.001 63.2±12.3 68.1±12.7 <0.001
BMI, m2/kg 28.3±5.0 28.3±6.6 0.90 28.9±5.2 29.1±6.5 0.24
Diabetes mellitus 15.1 (770) 18.6 (245) 0.002 20.6 (1097) 24.2 (412) 0.002
eGFR, mL/min 98.0±37.8 79.3±38.8 <0.001 100.1±40.5 82.2±41.8 <0.001
Previous CABG and/or PCI 11.3 (577) 7.9 (104) <0.001 23.3 (1240) 17.4 (296) <0.001
CVD 2.5 (127) 4.3 (57) <0.001 3.3 (176) 4.3 (73) 0.06
PVD 2.2 (110) 1.8 (24) 0.45 3.4 (181) 3.9 (66) 0.36
OAC therapy 2.2 (112) 2.3 (30) 0.85 4.0 (212) 4.3 (74) 0.52
Time of symptom onset
am to 8 pm 63.2 (2908) 62.7 (731) 0.75 60 (2124) 56.8 (630) 0.06
pm to 7 am 36.8 (1694) 37.3 (435) 40.0 (1418) 43.2 (479)
STD time, min 148.5 [85.2‐360.4] 190.1 [100.5‐421.6] <0.001 478.4 [146.4‐1321.6] 485.0 [155.1‐1312.9] 0.67
Prehospital cardiac arrest 9.6 (491) 5.7 (75) <0.001 1.0 (54) 0.5 (8) 0.04
Prehospital ECG notification 48.3 (2472) 46.5 (612) 0.24 ··· ··· ···

Values are mean±standard deviation or % (number) or median [IQR]. BMI indicates body mass index; CABG, coronary artery bypass grafting; CVD, cerebrovascular disease; eGFR, estimated glomerular filtration rate; IQR, interquartile range; MI, myocardial infarction; NSTEMI, non–ST‐segment–elevation myocardial infarction; OAC, oral anticoagulation; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; STD time, symptom‐to‐door time; STEMI, ST‐segment–elevation myocardial infarction.